Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haiying Fu

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Leukemia & Lymphoma|August 22, 2020
Clinical characteristics and survival of extranodal natural killer/T-cell lymphoma: a single-center 12-year retrospective analysisYi Chen, Luting Luo, Xiaoyun Zheng, et al.
Journal of Hazardous Materials|June 27, 2026
Time-dependent citrate-mediated precipitation inhibition in uranium column leaching: Mechanistic insights into pore evolution and uranium migrationXiaowei Zhou, Jing Sun, Qian Li, et al.
Journal of Hazardous Materials|November 1, 2020
Highly efficient actinide(III)/lanthanide(III) separation by novel pillar[5]arene-based picolinamide ligands: A study on synthesis, solvent extraction and complexationYimin Cai, Seraj A Ansari, Kuirong Fu, et al.
Hepatology (Baltimore, Md.)|October 25, 2018
Glypican-3-Specific Antibody Drug Conjugates Targeting Hepatocellular CarcinomaYing Fu, Daniel J Urban, Roger R Nani, et al.
Journal of the National Cancer Center|July 22, 2024
The role of radiotherapy in patients with refractory Hodgkin's lymphoma after treatment with brentuximab vedotin and/or immune checkpoint inhibitorsRuizhi Zhao, Han Shao, Guiqing Shi, et al.
Journal of Translational Medicine|November 14, 2023
A novel two-step administration of XPO-1 inhibitor may enhance the effect of anti-BCMA CAR-T in relapsed/refractory extramedullary multiple myelomaDi Wang, Haiying Fu, Yimei Que, et al.
Gastroenterology|February 16, 2020
Persistent Polyfunctional Chimeric Antigen Receptor T Cells That Target Glypican 3 Eliminate Orthotopic Hepatocellular Carcinomas in MiceDan Li, Nan Li, Yi-Fan Zhang, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Leukemia & Lymphoma|August 22, 2020
Clinical characteristics and survival of extranodal natural killer/T-cell lymphoma: a single-center 12-year retrospective analysisYi Chen, Luting Luo, Xiaoyun Zheng, et al.
Journal of Hazardous Materials|June 27, 2026
Time-dependent citrate-mediated precipitation inhibition in uranium column leaching: Mechanistic insights into pore evolution and uranium migrationXiaowei Zhou, Jing Sun, Qian Li, et al.
Journal of Hazardous Materials|November 1, 2020
Highly efficient actinide(III)/lanthanide(III) separation by novel pillar[5]arene-based picolinamide ligands: A study on synthesis, solvent extraction and complexationYimin Cai, Seraj A Ansari, Kuirong Fu, et al.
Hepatology (Baltimore, Md.)|October 25, 2018
Glypican-3-Specific Antibody Drug Conjugates Targeting Hepatocellular CarcinomaYing Fu, Daniel J Urban, Roger R Nani, et al.
Journal of the National Cancer Center|July 22, 2024
The role of radiotherapy in patients with refractory Hodgkin's lymphoma after treatment with brentuximab vedotin and/or immune checkpoint inhibitorsRuizhi Zhao, Han Shao, Guiqing Shi, et al.
Journal of Translational Medicine|November 14, 2023
A novel two-step administration of XPO-1 inhibitor may enhance the effect of anti-BCMA CAR-T in relapsed/refractory extramedullary multiple myelomaDi Wang, Haiying Fu, Yimei Que, et al.
Gastroenterology|February 16, 2020
Persistent Polyfunctional Chimeric Antigen Receptor T Cells That Target Glypican 3 Eliminate Orthotopic Hepatocellular Carcinomas in MiceDan Li, Nan Li, Yi-Fan Zhang, et al.
Pageof 8